AU3483497A - Solid solution of an antifungal agent with enhanced bioavailability - Google Patents
Solid solution of an antifungal agent with enhanced bioavailabilityInfo
- Publication number
- AU3483497A AU3483497A AU34834/97A AU3483497A AU3483497A AU 3483497 A AU3483497 A AU 3483497A AU 34834/97 A AU34834/97 A AU 34834/97A AU 3483497 A AU3483497 A AU 3483497A AU 3483497 A AU3483497 A AU 3483497A
- Authority
- AU
- Australia
- Prior art keywords
- solid solution
- antifungal agent
- enhanced bioavailability
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67270696A | 1996-06-28 | 1996-06-28 | |
| US08672706 | 1996-06-28 | ||
| PCT/US1997/010120 WO1998000113A1 (en) | 1996-06-28 | 1997-06-25 | Solid solution of an antifungal agent with enhanced bioavailability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3483497A true AU3483497A (en) | 1998-01-21 |
Family
ID=24699673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU34834/97A Abandoned AU3483497A (en) | 1996-06-28 | 1997-06-25 | Solid solution of an antifungal agent with enhanced bioavailability |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0954288B1 (enExample) |
| JP (1) | JP2000514057A (enExample) |
| AT (1) | ATE273002T1 (enExample) |
| AU (1) | AU3483497A (enExample) |
| DE (1) | DE69730241T2 (enExample) |
| ES (1) | ES2224256T3 (enExample) |
| WO (1) | WO1998000113A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
| US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
| NZ504834A (en) * | 1997-12-22 | 2001-12-21 | Schering Corp | Tricyclic amide molecular dispersion composition with enhanced bioavailability |
| US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
| JP5159012B2 (ja) | 1999-12-23 | 2013-03-06 | メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド | 不良溶解性の薬物に対する改良された医薬組成物 |
| GB0019296D0 (en) * | 2000-08-07 | 2000-09-27 | Nipa Lab Limited | Treatment for part processed leather |
| ITMI20022748A1 (it) | 2002-12-23 | 2004-06-24 | Eurand Int | Dispersioni solide stabilizzate di farmaco in un carrier organico e procedimento per la loro preparazione. |
| ITMI20032020A1 (it) | 2003-10-17 | 2005-04-18 | Italfarmaco Spa | Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici |
| JP2010526848A (ja) * | 2007-05-11 | 2010-08-05 | エフ．ホフマン−ラ ロシュ アーゲー | 難溶性薬物用の医薬組成物 |
| JP2015531749A (ja) | 2012-06-21 | 2015-11-05 | メイン ファーマ インターナショナル プロプライエタリー リミテッドＭａｙｎｅ Ｐｈａｒｍａ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｐｔｙ．Ｌｔｄ． | イトラコナゾール組成物及び投与剤形、並びにその使用方法 |
| WO2016198983A1 (en) | 2015-06-09 | 2016-12-15 | Bend Research Inc. | Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules |
| US11058682B2 (en) | 2015-08-08 | 2021-07-13 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Gastro-resistant formulation containing posaconazole |
| EP3925601B1 (en) | 2016-02-26 | 2024-07-17 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor |
| TR201620462A2 (tr) | 2016-12-31 | 2018-07-23 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ |
| US10702520B1 (en) | 2019-01-29 | 2020-07-07 | Slayback Pharma Llc | Pharmaceutical compositions of posaconazole |
| EP4196096A1 (en) | 2020-08-13 | 2023-06-21 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Gastro-resistant high-strength formulation containing posaconazole |
| EP4091604B1 (en) | 2021-11-25 | 2024-04-03 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Granules containing posaconazole |
| WO2023012378A1 (en) | 2021-11-25 | 2023-02-09 | Alfred E. Tiefenbacher (Gmbh Und Co. Kg) | Granules containing posaconazole |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG43179A1 (en) * | 1991-12-18 | 1997-10-17 | Warner Lambert Co | A process for the prepatation of a solid dispersion |
| DK0736030T3 (da) * | 1993-12-21 | 2001-10-29 | Schering Corp | Fungicide tetrahydrofuraner |
-
1997
- 1997-06-25 DE DE69730241T patent/DE69730241T2/de not_active Expired - Lifetime
- 1997-06-25 ES ES97931119T patent/ES2224256T3/es not_active Expired - Lifetime
- 1997-06-25 WO PCT/US1997/010120 patent/WO1998000113A1/en not_active Ceased
- 1997-06-25 AT AT97931119T patent/ATE273002T1/de not_active IP Right Cessation
- 1997-06-25 JP JP10504146A patent/JP2000514057A/ja not_active Ceased
- 1997-06-25 EP EP97931119A patent/EP0954288B1/en not_active Expired - Lifetime
- 1997-06-25 AU AU34834/97A patent/AU3483497A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998000113A1 (en) | 1998-01-08 |
| DE69730241D1 (de) | 2004-09-16 |
| EP0954288B1 (en) | 2004-08-11 |
| EP0954288A1 (en) | 1999-11-10 |
| JP2000514057A (ja) | 2000-10-24 |
| ES2224256T3 (es) | 2005-03-01 |
| DE69730241T2 (de) | 2005-08-11 |
| ATE273002T1 (de) | 2004-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE273002T1 (de) | Feste lösung eines fungizids mit erhöhter bioverfügbarkeit | |
| CA2098256A1 (en) | Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals | |
| EA199600104A1 (ru) | Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты | |
| MD1233C2 (ro) | Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora | |
| CA2374003A1 (en) | Improved cellular uptake of bioactive agents | |
| BG103268A (en) | Propionic acid derivatives and their application | |
| CA2227901A1 (en) | Improved cement admixture product | |
| GB9722426D0 (en) | Controlled release formulations | |
| CA2123052A1 (en) | Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
| EP1003526A4 (en) | COVALENT-TIED N, O-CARBOXYMETHYLCHITOSAN AND ITS USE | |
| CA2244785A1 (en) | Pentafluorobenzenesulfonamides and analogs | |
| HU903094D0 (en) | Process for the preparation of antiphlogistic amino-phenol derivatives | |
| CA2165971A1 (en) | Methylphosphonic acid ester, process for preparing the same and its use | |
| CA2285242A1 (en) | Mixture of primary fatty acids obtained from sugar cane wax | |
| CA2155323A1 (en) | Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof | |
| CA2181985A1 (en) | Modified-release metronidazole compositions and methods for making and using same | |
| CA2046069A1 (en) | Treatment of inflammatory diseases with 15-keto-prostaglandin compounds | |
| KR960703863A (ko) | 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer) | |
| AU644474B2 (en) | Heteroarylmethylbenzenes | |
| AU1303099A (en) | Herbicidal furanyl- and thienyloxyazines | |
| CA2258679A1 (en) | Solid solution of an antifungal agent with enhanced bioavailability | |
| AU2566101A (en) | Compounds and methods for the treatment of pain | |
| WO2001017955A3 (en) | Hydroxyacetamidobenzenesulphonamide derivatives | |
| NO177484C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler | |
| SE9902742D0 (sv) | New pharmaceutical formultion |